These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment options for heparin-induced thrombocytopenia. Greinacher A Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978 [TBL] [Abstract][Full Text] [Related]
5. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia. Lubenow N; Greinacher A Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002 [TBL] [Abstract][Full Text] [Related]
6. Overview of heparin-induced thrombocytopenia. Spinler SA; Dager W Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S5-11. PubMed ID: 14593977 [TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Warkentin TE; Greinacher A Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477 [TBL] [Abstract][Full Text] [Related]
8. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care]. Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720 [TBL] [Abstract][Full Text] [Related]
12. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience. Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975 [TBL] [Abstract][Full Text] [Related]
14. [Heparin-induced type II thrombocytopenia--new views on diagnosis and therapy]. Antonijević N; Stanojević M; Milosević R; Miković D; Kovac M; Terzić B; Vasiljević Z Med Pregl; 2003; 56(5-6):247-50. PubMed ID: 14565048 [TBL] [Abstract][Full Text] [Related]
15. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Greinacher A Semin Thromb Hemost; 2004 Jun; 30(3):315-27. PubMed ID: 15282654 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Dang CH; Durkalski VL; Nappi JM Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503 [TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia in intensive care patients. Selleng K; Warkentin TE; Greinacher A Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253 [TBL] [Abstract][Full Text] [Related]
19. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Seybert AL; Coons JC; Zerumsky K Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327 [TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment. Arnold RJ; Kim R; Tang B Cardiol Rev; 2006; 14(1):7-13. PubMed ID: 16371760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]